Ing Groep Nv Bausch Health Companies Inc. Transaction History
Ing Groep Nv
- $15.5 Billion
- Q2 2025
A detailed history of Ing Groep Nv transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Ing Groep Nv holds 5,000,000 shares of BHC stock, worth $33.1 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
5,000,000
Previous 5,000,000
-0.0%
Holding current value
$33.1 Million
Previous $32.4 Million
2.94%
% of portfolio
0.22%
Previous 0.23%
Shares
9 transactions
Others Institutions Holding BHC
# of Institutions
253Shares Held
240MCall Options Held
2.46MPut Options Held
8.42M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$230 Million2.99% of portfolio
-
Goldentree Asset Management LP New York, NY34.3MShares$226 Million23.91% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny32.8MShares$217 Million11.35% of portfolio
-
Nomura Holdings Inc Tokyo, M021.5MShares$142 Million0.31% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$85.9 Million0.18% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.39B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...